Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anti‐centromere antibodies in patients with systemic lupus erythematosus

1 Jan 2006

Abstract excerpt

BACKGROUND: Anti-centromere autoantibodies (ACA) are frequently detected in systemic sclerosis (SScl), especially in the calcinosis, Raynaud phenomenon, esophageal dysmotility, sclerodactyly, telangiectasia (CREST) syndrome, in which a prevalence of 55% has been reported. The presence of ACA in systemic lupus erythematosus (SLE) is so rare that its detection can raise serious doubts about the validity of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Inflammatory Myopathies and Dermatomyositis
Share to Systemic Lupus Erythematosus Research
Share to Systemic Sclerosis and Related Diseases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16882593
DOI: 10.1080/03009740600588376

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anti‐centromere antibodies in patients with systemic lupus erythematosusPMID 16882593Read ↗

Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study.Semantic proximity Read ↗

Anti-centromere antibody-positive subjects presenting with hypertensive emergency and renal dysfunction in the absence of skin manifestations: a variant of systemic sclerosis or a novel entity?Semantic proximity Read ↗

Anti-CENP-B polarity divides SLE: divergent clinical-immune phenotypes and distinct treatment responses.Semantic proximity Read ↗

Molecular subtypes of systemic sclerosis in association with anti-centromere antibodies and digital ulcersSemantic proximity Read ↗

Disease-related autoantibody profile in patients with systemic sclerosisSemantic proximity Read ↗

A clinical and histopathological analysis of the anti-centromere antibody positive subset of primary Sjögren's syndrome.Semantic proximity Read ↗

Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosisSemantic proximity Read ↗

Centromere defects, chromosome instability, and cGAS-STING activation in systemic sclerosisSemantic proximity Read ↗

Anticentromere antibody-positive primary Sjögren's syndrome: Epitope analysis of a subset of anticentromere antibody-positive patientsSemantic proximity Read ↗

Anti-centromere antibodies target centromere–kinetochore macrocomplex: a comprehensive autoantigen profilingSemantic proximity Read ↗

Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma.Semantic proximity Read ↗

HLA class II genes associated with anticentromere antibody in Japanese patients with systemic sclerosis (scleroderma).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.